Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Early research (Phase 1)Looking for participantsNCT06245746
What this trial is testing

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075030
What this trial is testing

AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced Anemia
Kind Pharmaceuticals LLC 36
Large-scale testing (Phase 3)Study completedNCT00148421
What this trial is testing

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Who this might be right for
Anemia
Amgen
Post-approval studies (Phase 4)Study completedNCT00117117
What this trial is testing

Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

Who this might be right for
Anemia
Amgen 2,423
Early research (Phase 1)Study completedNCT04667533
What this trial is testing

Desidustat in the Treatment of Chemotherapy Induced Anemia

Who this might be right for
Anemia of Chronic Kidney DiseaseChemotherapy Effect
Zydus Lifesciences Limited 24
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Large-scale testing (Phase 3)Study completedNCT05301517
What this trial is testing

Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Who this might be right for
Chemotherapy Induced Anemia
Kyntra Bio 159
Not applicableUnknownNCT02860598
What this trial is testing

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

Who this might be right for
AnemiaAcute Myeloid Leukemia
Hospices Civils de Lyon 104
Not applicableStudy completedNCT02158169
What this trial is testing

Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology

Who this might be right for
Chemotherapy-induced Anemia
Hospira, now a wholly owned subsidiary of Pfizer 2,167
Not applicableStudy completedNCT01444456
What this trial is testing

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Who this might be right for
AnemiaBreast CancerCancer+11 more
Amgen 1,262
Large-scale testing (Phase 3)UnknownNCT05704894
What this trial is testing

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Who this might be right for
AnemiaNeoplasmsChemotherapeutic-Induced Anemia
Blau Farmaceutica S.A. 320
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Testing effectiveness (Phase 2)UnknownNCT05299411
What this trial is testing

Intravenous Iron Infusion on Chemotherapy-induced Anemia

Who this might be right for
Colon CancerChemotherapeutic-Induced Anemia
Korea University Guro Hospital 80
Early research (Phase 1)Study completedNCT01280240
What this trial is testing

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Who this might be right for
Patients With Chemotherapy Induced Anemia (CIA)
Pharmacosmos A/S 11
Testing effectiveness (Phase 2)Study completedNCT00338416
What this trial is testing

An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks

Who this might be right for
CancerAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 115
Testing effectiveness (Phase 2)Study completedNCT00338299
What this trial is testing

Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Testing effectiveness (Phase 2)UnknownNCT05672420
What this trial is testing

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Who this might be right for
Hematologic NeoplasmsNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 181
Early research (Phase 1)Study completedNCT00080925
What this trial is testing

T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
National Institutes of Health Clinical Center (CC) 20
Testing effectiveness (Phase 2)Looking for participantsNCT06737081
What this trial is testing

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Who this might be right for
Anemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 60
Next Page